Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018-2020.
Govorkova EA, Takashita E, Daniels RS, Fujisaki S, Presser LD, Patel MC, Huang W, Lackenby A, Nguyen HT, Pereyaslov D, Rattigan A, Brown SK, Samaan M, Subbarao K, Wong S, Wang D, Webby RJ, Yen HL, Zhang W, Meijer A, Gubareva LV.
Govorkova EA, et al. Among authors: webby rj.
Antiviral Res. 2022 Apr;200:105281. doi: 10.1016/j.antiviral.2022.105281. Epub 2022 Mar 12.
Antiviral Res. 2022.
PMID: 35292289
Free PMC article.
Review.